Israel Startup Licenses Stanford Institute Metabolites To Develop Weight Loss Supplements

Israeli startup by biomedical researcher and entrepreneur Morris Laster using research from ChEM-H Institute scholar at Stanford to will develop and market compounds as nutraceuticals to offer an effective, affordable and side-effect-free solution for weight loss.

• Source: Shutterstock

There’s more to dietary ingredients’ potential in weight loss than being used to offset side effects of using GLP-1 drugs consumers are prescribed as obesity treatments, Metabolize.Life asserts in licensing two metabolites from Stanford University’s Office of Technology Licensing.

More from Deals

More from Biotech